Pilot Study of Quercetin Patients With Dyskeratosis Congenita/Telomere Biology Disorders
The purpose of this study is to see if a vitamin-like substance called quercetin is safe for people who have a rare condition called Dyskeratosis congenita (DC) or telomere biology disorders (TBD).
• Diagnosis of DC/TBD deficiency as defined by at least one of the following:
‣ Age adjusted mean-telomere length of \<1 percentile in all tested peripheral blood cells such as granulocytes, lymphocytes, B-cells, naïve T-cells, memory T-cells, and NK cells
⁃ A pathogenic or likely pathogenic mutation in DKC1, TERC, TERT, NOP10, NHP2, TINF2, CTC1, PARN, RTEL1, ACD, NAF1, ZCCHC8, or WRAP53
• Patients ≥ 2.0 years of age\*
‣ The first three enrolled patients must be ≥ 10.0 years of age
• Able to take medication orally